• Charles M. Roth
  • Charles M. Roth
  • Professor
  • Department: Department of Chemical & Biochemical Engineering
  • Program(s): Biochemistry Graduate Program, Cell and Developmental Biology Graduate Program, Microbiology and Molecular Genetics Graduate Program
  • Phone: 1.8484456686
  • Rutgers University
  • 599 Taylor Road
  • Piscataway, NJ 08854
  • Key Words: Gene-based therapeutics; bioinformatics and systems biology; hepatocyte differentiation; novel strategies for treatment of brain tumors

Our work falls under a broad umbrella of Molecular Bioengineering: developing an understanding of molecular interactions in a biological context and exploiting this knowledge for the improved design of bioengineered products. This encompasses activities crossing interdisciplinary boundaries and including elements of biophysics, synthetic chemistry, engineering thermodynamics and kinetics, cell and molecular biology, and physiology. Examples of ongoing and possible projects are outlined briefly below.

Molecular Bioengineering of Antisense Oligonucleotides

The sequencing of the human genome is more or less completed, with the promise of great improvements in understanding of human biology and concomitant advances in diagnosis and treatment of disease. Several technologies have emerged to inhibit the expression of specific target genes based on their gene sequence. We are working towards overcoming some of the technical barriers to two of the most promising -- antisense oligonucleotides (AS ONs) and short interfering RNAs (siRNAs). In one project, we have developed a molecular thermodynamic model of DNA:RNA binding that we are using to rationally design AS ONs of high affinity and rapid hybridization kinetics, and we are now investigating the extension of this methodology to siRNA design. In a second project, we use cell-specific ligands and biocompatible polymers to delivery oligonucleotides to cells with improved efficiency and selectivity.

Genomics and Proteomics of Hepatic Function

Efforts to develop "magic bullet" molecular therapeutics have been largely unsuccessful, in large part due to poor understanding of the underlying molecular basis for the disease being treated. Most physiological processes and disease conditions involve the concerted actions of large sets of genes, which may act synergistically, antagonistically, or in sophisticated feedback loops. We use computational and experimental approaches to analyze systems of molecules holistically, in an effort to rationally guide molecular strategies for engineering cell function. One application of this approach is the manipulation of transcription factor expression to confer differentiated function to cultured hepatocytes for tissue engineering applications. Another is the use of promoter binding site preferences and gene expression profiling to analyze dynamic responses of the liver to inflammatory stress.